Barclays »

Newamsterdam Pharma Co Nv shares owned by Barclays

Quarter-by-quarter ownership of Newamsterdam Pharma Co Nv (NAMS) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Newamsterdam Pharma Co Nv

Tip: Access up to 7 years of quarterly data

All positions including Newamsterdam Pharma Co Nv held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Newamsterdam Pharma Co Nv by Barclays

Quarter filed Position value Share count Share price at filing
2024-09-30 $126k 7.6k 16.59
2024-06-30 $8.0k 397 20.15
2024-03-31 $2.0k 94 21.28
2023-12-31 $6.0k 513 11.70
2023-09-30 $5.0k 513 9.75

More positions owned by Barclays

SPDR S&ampP 500 ETF TR Fund (SPY)
Invesco Qqq Tr Opt Put Option (QQQ)
Microsoft Corp Opt Call Option (MSFT)
Ishares Tr Opt Call Option (IWM)
Apple Opt Put Option (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Inc Class A cs (GOOGL)
Tesla Opt Put Option (TSLA)
Ishares Tr Fund (HYG)
Facebook Inc cl a (META)
Berkshire Hathaway (BRK.B)
Broadcom (AVGO)
Visa (V)
Alphabet Opt Put Option (GOOG)

View all positions for Barclays

Top funds holding Newamsterdam Pharma Co Nv

Frazier Life Sciences Management
Fcpm Iii Services B.v.
Bain Capital Life Sciences Investors
RA Capital Management
Viking Global Investors
Medicxi Ventures Management
Cormorant Asset Management
BVF
Woodline Partners
Jennison Associates
Henderson Group
Pictet Asset Management Holding SA
Siren
Deerfield Management Company
Avidity Partners Management

View all funds holding Newamsterdam Pharma Co Nv